In endocrine-resistant and triple-negative breast cancer cell lines, PKCα plays a key role in maintaining their migratory and invasive phenotypes through FOXC2-mediated repression of p120-catenin [101]. Here, PRKCA is linked to triple-negative breast carcinoma.